Celltrion Allies With 180 Life Sciences On Repurposing Biosimilars
Strikes Deal To Supply Anti-TNF Products For Trials In Novel Indications
• By David Wallace
Celltrion and 180 Life Sciences are collaborating on repurposing biosimilars • Source: Shutterstock 
